The Future

Is a Healthy One

The UK CBD market-place is at an early stage but it offers the greatest prize of future sales and return on invested capital. If the UK trend and changes in legislation follow the story in the USA and Canada the picture becomes clearer.

Marketplace

Recent history has shown an exponential number of cannabis-based medicinal companies and wellbeing products competing for the ‘emerging’ demand and profiting handsomely in revenue. In a recent article, CBNC.com stated ‘Legal marijuana was a $10.4 billion industry in the U.S in 2018’.

“It is expected that U.S. consumer sales of cannabidiol (CBD) will reach around 1.8 billion U.S. dollars by 2022. That would be a massive increase from around half a billion dollars in 2018. Thus, the CBD consumer market is following the trend of the total legal cannabis market in the United States, which is projected to be a 23-billion-dollar business by 2025.”
Source: Statista Global Data Platform 9 August 2019
https://www.statista.com/statistics/760498/total-us-cbd-sales/

Prohibition Partners project a £16.5bn UK market forecast and he said that he expected the UK market to open up to recreational use in three to five years. “Establishment of a functioning medical cannabis market would help destigmatise it with a view to having a rational debate around recreational cannabis in a couple of years’ time.”

Source: Daragh Anglim, MD at cannabis consultancy Prohibition Partners in the FT.

https://www.ft.com/content/8c82db1a-a4c0-11e9-a282-2df48f366f7d

CBD is interesting

CBD continues to inspire. The potential for the legal (medical) marijuana market and for further medical research is the future, CBD is set to be ‘the new medicine’. With more pharmaceutical companies entering the CBD market, the necessary medical research and clinical trials will result in even more high-quality evidence.

Already, The World Health Organization states that CBD shows no abuse or dependence potential and that “there is no evidence of public health related problems associated with the use of pure CBD”. Today, CBD is used to treat symptoms of anxiety, insomnia, and many types of chronic pain as well as specific conditions, notably:

In the UK and the rest of the world, there are 39 different conditions that have been evidenced as being either helped or cured by the use of medicinal cannabis and clearly, as more research is conducted, this list will grow. Already, those at the sharp end - living with constant pain, debilitating or terminal illnesses - are fundraising, lobbying and raising awareness of the issues around and need for consistent, affordable and reliable supply for what they may have been fortunate to have been prescribed.

The future will see Medicaleaf involved in this medical Research and Development, participating in the influencing and development of future legislation and regulation in the UK and in the emerging technology. The development of our innovative app designed to gather individual’s data, medical history and evidential tests to make and review a parametric prescription compared against meta data that any medical specialist can safely rely for prescribing is already underway, working with NIHR/NHS to demonstrate concept and efficacy.

A comprehensive guide to CBD published by Forbes illustrates the growing number of CBD products and the rise in popularity following recent research. “All of a sudden CBD products started showing up everywhere, with oils and gummies becoming the most popular products early on.” With the caveat that “Not all CBD products work the same”.
https://www.forbes.com/sites/joresablount/2019/09/11/what-is-cbd-heres-the-complete-guide/#31d2d29238d5

Commercially, there is currently huge demand for CBD infused health, wellbeing and cosmetic products. “As retailers decide whether cannabidiol (CBD) products are an emerging trend or just hype, new research from Acosta finds that more than a quarter of U.S. consumers are now using them.”
Source: Supermarket News, “New Acosta study gives snapshot of potential $20 billion market” 10 Sept 2019
https://www.supermarketnews.com/consumer-trends/just-who-cbd-product-customer

• Multiple Sclerosis
• Spinal Cord Injury and Spinal Cord Disease
• Cancer
• HIV/AIDS
• Arthritis
• Epilepsy
• Inflammatory Bowel Disease
• End of Life Care
• Insomnia

With every kind of product imaginable being created, from CBD water and other soft drinks; beer, gin, tea, coffees, cooking oil and cupcakes; massage oils, lubes, pessaries and patches, pills, potions and lotions; chewing gum, gummies, drops and vapes to pet care, CBD-infused pillowcases and Yoga classes offering CBD-assisted asanas, and the list is grows daily.

Medicaleaf will be the 'trusted' brand and 'household name' vital as the UK market develops. We will be the 'go to' brand that customers search for when buying any product so that consumers know how CBD products work for them. Whilst we will not necessarily manufacture all of the available products we will focus on brand awareness and PR so that the brand can leverage any developing trends to create and develop its own marketplace in the UK as well as fulfil it.

Copyright All Right Reserved Medicaleaf | Privacy Notice | Website by Plan B Creative

COVID-19 UPDATE

The Medicaleaf Team remains in place to manage the business and deal with our stakeholders enquires and questions. The team are being protected through our Work from Home policy and will respond to your needs in our usual proactive manner.